2025 Breast Cancer Immunotherapy Trial Updates Breast Cancer 3 Mins Read On September 6, 2025, at the MOASC and ANCO Immuno-Oncology Symposium, Dr. Alexis LeVee, MD, from UCLA’s Division of Hematology/Oncology,…
Nivolumab: Does the Extended CheckMate-274 Results Prove It’s the Ultimate for MIBC? ASCO GU 2025 ASCO GU 3 Mins Read Extended CheckMate-274 Results Show Continued Benefit With Nivolumab in MIBC Date: February 14, 2025 Author: Dr. Matthew I. Milowsky, MD,…
Melanoma Cancer Adjuvant Therapy: Final Analysis Phase 3 KEYNOTE-716 Melanoma Skin Cancer Treatment 3 Mins Read Jason Luke, MD, FACP, a renowned medical professional affiliated with the University of Pittsburgh Medical Center (UPMC), recently conducted a…
